Philips Partners with LeQuest to Provide Online Interactive Training in Ultrasound

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and LeQuest, a leading provider of online interactive simulation-based training for the use of medical devices [1], today announced a partnership to provide online interactive training for the Philips Ultrasound Affiniti system. As a result, medical staff can train individually at their own convenience without the need for equipment, avoiding the resulting loss of operational time on the system, as well as supporting faster onboarding and increasing confidence through practice with realistic simulation scenarios. Healthcare providers benefit from improved workflow, operational efficiencies and better-trained staff.

The Affiniti system offers healthcare professionals a powerful combination of performance and workflow for quick and efficient diagnosis with low operating cost, providing exceptional image quality across applications such as radiology, obstetrics & gynecology, and cardiology. By providing a flexible training solution to healthcare providers, the partnership supports them to achieve key parts of the quadruple aim: an improved experience for staff and patients, better health outcomes and a lower cost of care.

"Partnering with LeQuest enables us to further expand our offering of solutions that aid in optimizing the healthcare ecosystem," said Bich Le, Senior Vice President and General Manager Ultrasound at Philips. "As the role of ultrasound continues to expand, new capabilities, such as remote clinical collaboration and virtual training, have been particularly valuable during the COVID-19 pandemic, enabling providers to reduce in-person contact and reduce infection risk."

"At LeQuest our goal is to improve the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities," said Hicham Shatou, founder and CEO of LeQuest. "Our partnership with Philips is an important step on our path to achieving that ambition, extending the global reach of our capabilities and providing Philips ultrasound users with a hands-on experience of its Affiniti system in a virtual environment."

With the LeQuest training modules, users can master the system in an effective way, gain confidence by practicing with realistic simulation scenarios and learn and practice anytime, anywhere. Training modules are available for all models of the Affiniti system (Affiniti 30, 50, 70) with specific versions for each clinical segment (general imaging, obstetrics/gynecology, and cardiology). The LeQuest training modules for the Philips Ultrasound Affiniti system are currently available in LATAM, France, Benelux and Nordics and more countries will follow soon. For more information visit www.lequest.com/en/philips-affiniti.

The partnership with LeQuest adds to Philips' strong portfolio of Clinical Education Services in ultrasound. Helping to combat the COVID-19 pandemic, the company is also providing detailed, practical guidance to support clinicians using its ultrasound systems and software for patients affected by COVID-19. Through its Reacts collaborative platform, Philips is expanding its remote clinical collaboration and virtual training offerings across its portfolio.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

About LeQuest

LeQuest, founded in 2011 is a leading technology company focused on improving the quality of care by unlocking the potential of both medical technology as well as the competence of medical staff to use devices to the limit of their possibilities. We are developing online interactive simulation-based e- training for the use of medical devices. The LeQuest e-trainings accelerate the implementation of new medical equipment, close the consumption gap, and make users quickly gain confidence, knowledge and competence within a safe environment including certifying and re-certifying of the medical staff. LeQuest is a fast growing company. LeQuest was recently recognized as one of the 250 fastest-growing companies in the Netherlands for 2020.

1. Since 2017, Philips has owned a minority interest in LeQuest through its Philips Health Technology Venture Fund. For more information, please visit www.ventures.philips.com.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...